© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
June 07, 2008
LETTERS TO THE EDITORS
Adherence with statins over 8 years among members of Israel's largest HMO was found to be poor, especially among new immigrants.
This survey of 252 HMOs found that almost all measure their performance on multiple indicators of quality and most use these data in quality improvement activities.
This study highlights the difficulty many consumers have in understanding comparative plan information. It also suggests that presentation strategies may help consumers understand choices better.
This review suggests that only a few primary care quality measures, which usually are not found in claims data, have significant clinical and financial impact.
This retrospective study found no benefit of a disease management program compared with usual care on utilization of secondary prevention pharmacotherapies in postmyocardial infarction patients.
Recent events have cast doubt on the ability of disease management to reduce medical cost and to affect the quality of care.